Atrial conduction abnormalities in patients with psoriasis vulgaris

Kardiologia Polska

Volumn 73, Issue 8, 2015, Pages 637-643

  Tasal, Abdurrahman ^a   Guvenc, Tolga Sinan ^a   Kul, Seref ^a   Bacaksiz, Ahmet ^a   Erdogan, Ercan ^a   Sonmez, Osman ^a   Sevgili, Emrah ^a   Dizman, Didem ^a   Onsun, Nahide ^a   Ay, Nuray K ^a  

^a BEZMIALEM VAKIF UNIVERSITY   (Turkey)

Author keywords

Atrial fibrillation; Electromechanical delay; Psoriasis vulgaris

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; ATRIAL FIBRILLATION; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; ECHOCARDIOGRAPH; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM CONDUCTION; HUMAN; INTERATRIAL ELECTROMECHANICAL DELAY; INTRA LEFT ATRIAL ELECTROMECHANICAL DELAY; MAJOR CLINICAL STUDY; MALE; PSORIASIS AREA AND SEVERITY INDEX; PSORIASIS VULGARIS; ADOLESCENT; COMPLICATION; HEART ATRIUM; HEART MUSCLE CONDUCTION SYSTEM; MIDDLE AGED; PATHOPHYSIOLOGY; PSORIASIS; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; ATRIAL FIBRILLATION; C-REACTIVE PROTEIN; CHILD; FEMALE; HEART ATRIA; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED; PSORIASIS; RISK FACTORS; YOUNG ADULT;

EID: 84940118432     PISSN: 00229032     EISSN: 18974279     Source Type: Journal    
DOI: 10.5603/KP.a2015.0028     Document Type: Article

References (32)

1. Schön M.P., Boehncke WH Psoriasis. N Engl J Med, 2005; 352: 1899-1912.
2. Balta I, Balta S, Demirkol S., et al. Aortic arterial stiffiness is a moderate predictor of cardiovascular disease in patients with psoriasis vulgaris. Angiology, 2014; 65: 74-78.
3. Mehta NN, Yu Y, Pinnelas R et al. Attributable risk estimate of severe psoriasis on major cardiovascular events. Am J Med, 2011; 124: 775. e1-e6.
4. Ahlehoff O, Gislason GH, Jørgensen CH, et al. Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study. Eur Heart J, 2012; 33: 2054-2064.
5. Turpie AG. Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation. Ther Clin Risk Manag, 2014; 10: 197-205. eCollection 2014. Review.
6. Güvenç TS, Ilhan E, Hasdemir H et al. A novel explanation for the cause of atrial fibrillation seen in atherosclerotic coronary artery disease: "downstream inflammation" hypothesis. Med Hypotheses, 2010; 74: 665-667.
7. Perzanowski C, Ho AT, Jacobson AK Increased P-wave dispersion predicts recurrent atrial fibrillation after cardioversion. J Electrocardiol, 2005; 38: 43-46.
8. Özer N, Yavuz B., Can I et al. Doppler tissue evaluation of intra-atrial and interatrial electromechanical delay and comparison with P-wave dispersion in patients with mitral stenosis. J Am Soc Echocardiogr, 2005; 18: 945-948.
9. Louden BA, Pearce DJ, Lang W et al. A Simplified Psoriasis Area Severity Index (SPASI) for rating psoriasis severity in clinic patients. Dermatol Online J, 2004; 10: 7.
10. Amornpinyokeit N, Asawanonda P. 8-Methoxypsoralen cream plus targeted narrowband ultraviolet B for psoriasis. Photodermatol Photoimmunol Photomed, 2006; 22: 285-289.
11. Rich P, Scher RK Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis. J Am Acad Dermatol, 2003; 49: 206-212.
12. Prodanovich S, Kirsner RS, Kravetz JD et al. Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. Arch Dermatol, 2009; 145: 700-703.
13. Elder JT, Bruce AT, Gudjonsson JE et al. Molecular dissection of psoriasis: integrating genetics and biology. J Invest Dermatol, 2010; 130: 1213-1226.
14. Rico T, Marchione R, Kirsner RS Vascular disease in psoriasis. J Invest Dermatol, 2009; 129: 2327.
15. Flammer AJ, Ruschitzka F. Psoriasis and atherosclerosis: two plaques, one syndrome? Eur Heart J, 2012; 33: 1989-1991.
16. Patel RV, Shelling ML, Prodanovich S et al. Psoriasis and vascular disease-risk factors and outcomes: a systematic review of the literature. J Gen Intern Med, 2011; 26: 1036-1049.
17. Daudén E., Castañeda S, Suárez C et al. [Integrated approach to comorbidity in patients with psoriasis]. Actas Dermosifiliogr, 2012; 103: 1-64.
18. Darbar D, Herron KJ, Ballew JD et al. Familial atrial fibrillation is a genetically heterogeneous disorder. J Am Coll Cardiol, 2003; 41: 2185-2192.
19. Krahn AD, Manfreda J, Tate RB et al. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med, 1995; 98: 476-484.
20. Liberthson RR, Salisbury KW, Hutter AM Jr et al. Atrial tachyarrhythmias in acute myocardial infarction. Am J Med, 1976; 60: 956-960.
21. Ettinger PO, Wu CF, De La Cruz C Jr. et al. Arrhythmias and the "Holiday Heart": alcohol-associated cardiac rhythm disorders. Am Heart J, 1978; 95: 555-562.
22. Woeber KA. Thyrotoxicosis and the heart. N Engl J Med, 1992; 327: 94-98.
23. Yao SY, Chu JM, Chen KP et al. Inflammation in lone atrial fibrillation. Clin Cardiol, 2009; 32: 94-98.
24. Chen MC, Chang JP, Liu WH et al. Increased inflammatory cell infiltration in the atrial myocardium of patients with atrial fibrillation. Am J Cardiol, 2008; 102: 861-865.
25. Gelfand JM, Neimann AL, Shin DB et al. Risk of myocardial infarction in patients with psoriasis. JAMA, 2006; 296: 1735-1741.
26. Gelfand JM, Dommasch ED, Shin DB et al. The risk of stroke in patients with psoriasis. J Invest Dermatol, 2009; 129: 2411-2418.
27. Brauchli YB, Jick SS, Miret M et al. Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis. Br J Dermatol, 2009; 160: 1048-1056.
28. Kimball AB, Guerin A, Latremouille-Viau D et al. Coronary heart disease and stroke risk in patients with psoriasis: retrospective analysis. Am J Med, 2010; 123: 350-357.
29. Bacaksiz A, Erdogan E, Tasal A et al. Electrocardiographic P-wave characteristics in patients with psoriasis vulgaris. Ups J Med Sci, 2013; 118: 35-41.
30. Deniz A, Sahiner L, Aytemir K et al. Tissue Doppler echocardiography can be a useful technique to evaluate atrial conduction time. Cardiol J, 2012; 19: 487-493.
31. Coumbe AG, Pritzker MR, Duprez DA Cardiovascular risk and psoriasis: beyond the traditional risk factors. Am J Med, 2014; 127: 12-18.
32. Shimizu A, Fukatani M, Tanigawa M et al. Intra-atrial conduction delay and fragmented atrial activity in patients with paroxysmal atrial fibrillation. Jpn Circ J, 1989; 53: 1023-1030.